Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Clinical Nutrition

A risk prediction model based on immune-inflammatory-nutritional indicators for predicting 28-day mortality in sepsis patients with acute respiratory distress syndrome

Provisionally accepted
Qi  XinQi Xin*Xingbo  DangXingbo DangGongliang  DuGongliang DuYanlong  YangYanlong YangHaitao  JingHaitao Jing
  • Shaanxi Provincial People's Hospital, Xi'an, China

The final, formatted version of the article will be published soon.

Background: Sepsis is a life-threatening condition often complicated by organ dysfunction and is associated with a high mortality rate. The dysregulation of immune response, inflammation, and nutritional status are critical factors contributing to its pathogenesis. This study aimed to develop a nomogram that integrates prognostic immune-inflammatory-nutritional indicators with other clinical information to predict 28-day mortality in sepsis patients with acute respiratory distress syndrome (ARDS). Methods: Clinical data from 635 adult sepsis patients with ARDS were obtained from Shaanxi Provincial People's Hospital and randomly divided into a training set (n=477) and a validation set (n=158). To identify predictors of 28-day mortality in sepsis patients with ARDS, univariate analysis and least absolute shrinkage and selection operator (LASSO) regression were utilized. Subsequently, a multivariate logistic regression model was constructed to identify independent predictors. A nomogram was then developed by integrating the selected indicators. The model's performance was assessed with respect to discrimination, calibration, and clinical utility through the use of the AUC, calibration plots, and decision curve analysis (DCA). Results: The independent predictors utilized for the construction of the nomogram included the albumin-alkaline phosphatase ratio (AAPR), albumin-bilirubin grade (ALBI), neutrophil– lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and lactate-albumin ratio (LAR). Notably, the nomogram exhibited superior predictive performance, with an AUC of 0.873 in the training set and 0.837 in the validation set, as compared to the SOFA score, which showed an AUC of 0.689 in the training set and 0.684 in the validation set, for predicting 28-day mortality in sepsis patients with ARDS. The calibration plots demonstrated excellent consistency. DCA confirmed the model's clinical utility, showing a positive net benefit across a wide range of clinically relevant threshold probabilities (approximately 10% to 70%), which supports its potential to guide clinical decision-making. Conclusion: We have successfully developed and validated a robust nomogram that integrates seven readily accessible immune-inflammatory-nutritional indicators. This model serves as an individualized and precise tool for predicting the 28-day mortality risk in sepsis patients with acute respiratory distress syndrome (ARDS), thereby potentially enhancing early risk stratification and informing clinical decision-making.

Keywords: 28-day mortality, Acute Respiratory Distress Syndrome, Immune-inflammatory-nutritional indicators, nomogram, Sepsis

Received: 09 Dec 2025; Accepted: 09 Feb 2026.

Copyright: © 2026 Xin, Dang, Du, Yang and Jing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Qi Xin

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.